The effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4+Foxp3+CD25− T cells in patients with leukemic cutaneous T‐cell lymphoma

By  

Photodermatology, Photoimmunology & Photomedicine, Vol. 31, Iss. 4, 2015-07 ,pp. : 184-194

John Wiley & Sons Inc

Access to resources Recommend Favorite

Addition of a Topical Corticosteroid in the Early Phase of Alefacept Treatment for Psoriasis

By Bovenschen H. Jorn   Gerritsen Wil-Janne   de Jong Elke M.G. J.   van de Kerkhof Peter C. M.  

Acta Dermato-Venereologica, Vol. 86, Iss. 3, 2006-05 ,pp. : 281-282

Medical Journals Limited

Access to resources Recommend Favorite

Efalizumab, a reversible T-cell modulator for psoriasis

By Shear Neil   Langley Richard   Ho Vincent  

Journal of Cutaneous Medicine and Surgery, Vol. 9, Iss. 1, 2005-12 ,pp. : 4-9

Springer Publishing Company

Access to resources Recommend Favorite

Good clinical response to anti-psoriatic treatment with adalimumab and methotrexate does not inflict a direct effect on compartmentalization of T-cell subsets: A pilot study

By van Lingen Rosanne   de Jong Elke   Berends Maartje   Seyger Marieke   van Erp Piet   van de Kerkhof Peter  

Journal of Dermatological Treatment, Vol. 19, Iss. 5, 2008-01 ,pp. : 284-287

Informa Healthcare

Access to resources Recommend Favorite

Explorative immunohistochemical study to evaluate the addition of a topical corticosteroid in the early phase of alefacept treatment for psoriasis

By Bovenschen H.   Gerritsen W.   Rens D.   Seyger M.   Jong E.   Kerkhof P.  

Archives of Dermatological Research, Vol. 298, Iss. 9, 2007-02 ,pp. : 457-463

Springer Publishing Company

Access to resources Recommend Favorite